Abstract:Proc Amer Assoc Cancer Res, Volume 47, 2006 4662 Hepatocellular carcinoma (HCC) is one of the most common and lethal solid tumors in the world. HCC is typically refractory to almost all cytotoxic chemotherapeutic agents. OSU-03012 is a derivative of celecoxib, a cyclooxygenase (COX)-2 inhibitor. However, its primary mechanism of action is known as 3-phosphoinositide-dependent kinase-1 (PDK-1) inhibition and by which it induces apoptosis in certain cancer cells[Zhu J et al. , Cancer Res. 64:4309-18, 2004; Hsu AL et al. , J Biol. Chem . 275:11937-403. 2000]. This study sought to investigate if OSU-03012 may be effective in the treatment of HCC. OSU-03012 inhibited cell growth of Huh7, a human HCC cell line, in a dose-dependent manner, with IC50 at 1μM, which is well below the non-toxic serum concentration (5-20μM) in mice. Surprisingly, in this Huh7 cell model, western blotting analysis demonstrated that neither pPDK1 nor pAkt was suppressed by OSU-03012. Cell cycle analysis by flow cytometry indicated that OSU-03012 (5μM, 24h) significantly increased S-phase population, while did not alter sub-G1 population, suggesting that apoptosis is not a major mechanism of cell growth suppression. Western blotting analysis showed that OSU-03012 reduced protein level of cyclin D1. Furthermore, OSU-03012-treated cells exhibited cytoplasmic vacuoles which were positively stained by acridine orange and monodansylcadaverine, a phenomenon mimicking cell autophagy. The content in the OSU-03012-induced autophagosomes and its mechanistic linkage with the occurrence of autophagy-like cell death of Huh7 cells are under investigation. Together, our preliminary results indicate that OSU-03012 might be an effective therapeutic agent for HCC, but the mechanisms of action of this drug in HCC cells need to be further clarified. (This study was supported by grant DOH94-TD-B-111-001 from Department of Health, R.O.C. to National Clinical Research Center at National Taiwan University)

Induction of Mitotic Arrest and Apoptosis by a Novel Synthetic Quinolone Analogue, CWC-8, Via Intrinsic and Extrinsic Apoptotic Pathways in Human Osteogenic Sarcoma U-2 OS Cells.

Osu-03012, A Novel Celecoxib Derivative, Induces A Unique Autophagy-Like Cell Death In Human Hepatocellular Carcinoma Cells

Cyclovirobuxine D Inhibits the Growth of Osteosarcoma Cells Through the Induction of Autophagy Flux Arrest by Promoting Lysosomal Acidification

Induction of Apoptosis and Suppression of ERCC1 Expression by the Potent Amonafide Analogue 8-C in Human Colorectal Carcinoma Cells.

Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Novel Quinolone Chm-1 Induces Apoptosis and Inhibits Metastasis in A Human Osterogenic Sarcoma Cell Line

A New Synthetic Ursolic Acid Derivative IUA with Anti-Tumor Efficacy Against Osteosarcoma Cells Via Inhibition of JNK Signaling Pathway.

Novel quinazoline HMJ-30 induces U-2 OS human osteogenic sarcoma cell apoptosis through induction of oxidative stress and up-regulation of ATM/p53 signaling pathway.

Cantharidin Decreased Viable Cell Number in Human Osteosarcoma U-2 OS Cells Through G2/M Phase Arrest and Induction of Cell Apoptosis

The Newly Synthesized 2-Arylnaphthyridin-4-one, CSC-3436, Induces Apoptosis of Non-Small Cell Lung Cancer Cells by Inhibiting Tubulin Dynamics and Activating CDK1

Quinolone Analogue Inhibits Tubulin Polymerization and Induces Apoptosis Via Cdk1-involved Signaling Pathways

Synthesis and SAR Studies of Novel 6,7,8-Substituted 4-Substituted Benzyloxyquinolin-2(1H)-one Derivatives for Anticancer Activity.

8-Methoxyflindersine-Induced Apoptosis and Cell Cycle Disorder Involving MAPK Signaling Activation in Human Colorectal Cancer Cells

The Novel Synthesized 6-Fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (Ljj-10) Compound Exhibits Anti-Metastatic Effects in Human Osteosarcoma U-2 Os Cells Through Targeting Insulin-Like Growth Factor-I Receptor

Antitumor Activity of a Camptothecin Analogue,XY-8,and FCM Analysis

Wogonin Triggers Apoptosis in Human Osteosarcoma U-2 OS Cells Through the Endoplasmic Reticulum Stress, Mitochondrial Dysfunction and Caspase-3-dependent Signaling Pathways

Identification of (S)-1-(2-(2,4-difluorophenyl)-4-oxothiazolidin-3-yl)-3-(4-((7-(3-(4-ethylpiperazin-1-yl)propoxy)-6-methoxyquinolin-4-yl)oxy)-3,5-difluorophenyl)urea as a potential anti-colorectal cancer agent

Antitumor Potential of a Novel Camptothecin Derivative, ZBH-ZM-06

Curcin C inhibit osteosarcoma cell line U2OS proliferation by ROS induced apoptosis, autophagy and cell cycle arrest through activating JNK signal pathway

A Novel Derivative of Quinazoline, Wyk431 Induces G(2)/M Phase Arrest and Apoptosis in Human Gastric Cancer Bgc823 Cells Through the Pi3k/Akt Pathway